LivaNova PLC

The business, in plain English

LivaNova PLC booked $1.4B of revenue in FY2025 in the Healthcare sector and kept 67.7% of it as gross profit — a high-margin business by that measure. After every other cost, −17.5% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $254M (FY2013) to $1.4B (FY2025) — about 15.2% a year compounded over 12 years.

It earned 16.7% on invested capital in the latest filed year, FY2025. Across the full 13-year measurable filed record, median ROIC was 1.5%. Over the v3 recent window (10 measurable filed years), median ROIC was −1.7%. The Returns on Capital filter above scores it 4/100.

The balance sheet carried $377M of total debt in FY2025. Balance-Sheet Safety scores it 60/100.

Put together: Pricing Power is the strongest of the five filters (98/100) and Returns on Capital the weakest (4/100), which is how LIVN lands at 49/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.